North East and North Cumbria
ICS Formulary
 
back
3 Respiratory system

*Important*

The NENC ICB Respiratory Network recommends that all inhalers should be prescribed by brand for patient safety, to ensure that the correct device is dispensed to support correct technique and avoid patient confusion and medication errors.

Choice of inhaler device should be based on patient ability to use. Devices should be chosen based on availability for the type of drug to be prescribed and the patient’s ability to use it.

Refer to local guidelines for information on preferred options.

Note: All new patients should be started on the updated formulary choices as per local/national guidelines.

When inhalers are removed from the formulary, existing, stable, patients should continue to receive the non-formulary device. Treatment should not be changed unless a full face to face review has been conducted.

03-01-01-01 Short-acting beta2 agonists

Salbutamol
Formulary
  • REFER TO LOCAL GUIDELINES FOR ADVICE ON PREFERRED CHOICE
  • Easyhaler® breath actuated dry powder inhaler  100 mcg/puff (DPI) 
  • Accuhaler® breath actuated dry powder inhaler 200 mcg/puff (DPI)
  • 100 mcg/puff CFC-free MDI - Salamol® (pMDI)
  • 100 mcg/puff breath actuated CFC-free MDI (pMDI)
    • Airomir® Autohaler  
      • Salamol® Easi-Breathe - alternative for patients hypersensitive to lactose or milk protein
  • 2.5mg in 2.5ml & 5mg in 2.5ml nebules (Medicine Supply Notification 028 - Supply issue with salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials)
  • 2mg in 5ml sugar-free oral solution

 

Link  National Patient Safety Alert - Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials (26 February 2024)
Link  MHRA Drug Safety Update (Aug 2022): Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists

Green View adult BNF  View SPC online  View childrens BNF
Salbutamol Injection
Formulary
  • 500 mcg in 1ml & 5mg in 5ml injections  

 


Red View adult BNF  View SPC online  View childrens BNF
Terbutaline
Formulary
  • Turbohaler® 500 mcg/puff (DPI)

 


Green View adult BNF  View SPC online  View childrens BNF
Terbutaline Injection
Formulary
  • 500 mcg in 1ml injection

 


Red View adult BNF  View SPC online  View childrens BNF
Terbutaline Nebules
Formulary
  • 2.5mg/ml nebuliser solution



 

Link  MHRA Drug Safety Update (Aug 2022): Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists

Red View adult BNF  View SPC online  View childrens BNF